Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00516724
Status:
COMPLETED
Last Update Posted:
2024-05-10
First Post:
2007-08-13
Brief Title:
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin andor Paclitaxel
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2013-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-13
First Submit QC Date:
August 13 2007
Study First Post Date:
2007-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-09
Last Update Post Date:
2024-05-10
Last Update Post Date Type:
ACTUAL